Observations from ID and Beyond: Three Effective Treatments for COVID-19 Not in Treatment Guidelines — At Least Not Yet

Dr. Paul Sax discusses three studies presented at CROI that highlight promising outpatient COVID-19 treatments in HIV and ID Observations.

In the latest HIV and ID Observations, Dr. Paul Sax highlights three studies presented at CROI 2023 that looked at novel treatment options for COVID-19 — ensitrelvir, metformin, and pegylated interferon lambda.

Do you want to be notified whenever Dr. Sax posts? Sign up to receive notifications by email by using the Subscribe box.

Want to see more from NEJM Journal Watch? Register here.

Observations from ID and Beyond: Three Effective Treatments for COVID-19 Not in Treatment Guidelines — At Least Not Yet

Topics